Dent County Developmental Disabilities Board: Bids discussed; tax rate hearing scheduled thesalemnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesalemnewsonline.com Daily Mail and Mail on Sunday newspapers.
AUSTIN, Texas, Jun 03, 2021 (SEND2PRESS NEWSWIRE) Life Science industry organization BioAustin today announced changes to its leadership team, brand positioning, and long-term strategy focused on facilitating the continued growth of the life science industry in Central Texas. Over the past several years, Austin and the Central Texas region have developed into one of the fastest-growing life science hubs in the U.S. With more than 240 companies and a variety of nonprofit community ecosystem organizations involved in the life science sector, the Central Texas Region has emerged as a significant life science innovation center and is attracting investment for early-stage startups and relocations for established companies.
(AUSTIN, Texas) NEWS: Life Science industry organization BioAustin today announced changes to its leadership team, brand positioning, and long-term strategy focused on facilitating the continued growth of the life science industry in Central Texas. Over the past several years, Austin and the Central Texas region have developed into one of the fastest-growing life science hubs in the U.S. With more than 240 companies and a variety of nonprofit community ecosystem organizations involved in the life science sector, the Central Texas Region has emerged as a significant life science innovation center and is attracting investment for early-stage startups and relocations for established companies.
Sublingual delivery is an emerging strategy for vaccines
AUSTIN, Texas /Massachusetts Newswire – National News/ Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent 10238577). This latest patent expands the capabilities of Zeteo’s ZEOx1™ Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.
Sublingual delivery has emerged as a viable route of administration for vaccines and medications for pain, cardiovascular, allergy, seizure, sedation and emesis. The sublingual route avoids first pass metabolism and provides rapid systemic uptake into the body providing advantages over traditional oral medications.
eNewsChannels NEWS: Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route. :: News from eNewsChannels